Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now

Search Results for "MYC":

Results: 315

Quotes

MYXM MyCelx Technologies Corp Stock - London equities MYCR Mycronic publ AB Stock - Stockholm equities MYCOF Mydecine Innovations Group Inc Stock - OTC Markets equities MYCS Mycron Steel Bhd Stock - Kuala Lumpur equities MCDP Mycodern SA Stock - Warsaw equities MYCO Mydecine Innovations Group Inc Stock - CBOE Canada equities 4726 Mycenax Biotech Stock - TPEX equities PALM-MYCRD-P1 CRUDE PALM OIL – CIF ROTTERDAM Spot Commodity - ICE commodity
Show all (10)

News

SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities
By Investing.com

LINKÖPING, Sweden, April 17, 2024 /PRNewswire/ -- SimonMed Imaging ("SimonMed"), one of the largest outpatient medical imaging providers and radiology practices in the United States, announces the...

Evans Bancorp Announces First Quarter 2024 Conference Call and Webcast
By Investing.com

WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--Evans Bancorp, Inc. (the Company) (NYSE American: EVBN), a community financial services company serving Western New York since 1920, announced that it will...

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara ® (ustekinumab)
By Investing.com

SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be marketed in the...

Show all (240)

Analysis

Quickview: Resverlogix Corp
By Edison

Investment summary: Spin-out of BETi assetsResverlogix is planning to spin out RVX Therapeutics (RVXT), its subsidiary containing the firm’s BETi epigenetics platform assets. Shareholders will...

Leisure Stocks To Report Earnings On Jul 14: MYCC, SKIS
By Zacks Investment Research

With second-quarter earnings about to gather pace, the overall scenario is far from rosy. Notably, for the quarter, total earnings are expected to be down 6.2% on 0.6% lower revenues. Moreover,...

Medtronic's MyCareLink Data On Older Patients Found Positive
By Zacks Investment Research

Leading medical device player Medtronic plc (NYSE:HOLX) and Edward Lifesciences, Inc. (NYSE:EW) . Notably, Luminex sports a Zacks Rank #1 (Strong Buy), while Hologic and Edward Lifesciences carry a...

Show all (64)
Results: 10

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 240

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 64

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 1

Authors

Continue with Google
or
Sign up with Email